Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
